Executives
?
Nunes Anne
SVP, Chief Operations Officer
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK
1982862
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
14,211
Price per Share :
$16.19
Equivalence :
$230,076.09
Transaction History
-
M14,211 Shares After TransactionValue : $n/a$0.0Transaction Date : 10/01/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of RSUs granted on October 1, 2021.#2 Includes 634 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 14, 2024.#3 Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2024.#4 Reflects the closing price of ANIK common stock on October 1, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
-
F13,479 Shares After TransactionValue : $327,135.33$17,765.64Transaction Date : 10/01/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of RSUs granted on October 1, 2021.#2 Includes 634 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 14, 2024.#3 Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2024.#4 Reflects the closing price of ANIK common stock on October 1, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
-
M5,784 Shares After TransactionValue : $n/a$0.0Transaction Date : 10/01/23
-
Footnotes
-
-
Footnotes:#1 Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on October 1, 2021.#2 Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2023.#3 Reflects the closing price of ANIK common stock on September 29, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
-
F5,052 Shares After TransactionValue : $94,118.76$13,637.16Transaction Date : 10/01/23
-
Footnotes
-
-
Footnotes:#1 Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on October 1, 2021.#2 Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2023.#3 Reflects the closing price of ANIK common stock on September 29, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
-
M10,245 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Reflects the first vesting installment of RSUs granted on March 9, 2023.#2 Reflects the corrected Amount of Shares Beneficially Owned under Table I, Column 2 as reported in Form 3/A filed by the Reporting Person on January 12, 2024.#3 Includes 414 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023.#4 Reflects an aggregate of 968 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.#5 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.#6 Reflects the second vesting installment of RSUs granted on March 11, 2022.#7 Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.